موافقات الدواء

Asthma
Formoterol Fumarate/Beclometasone Dipropionate is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:
- patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled rapid-acting beta-agonist or
- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2- agonists.
COPD
Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators